Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies

BACKGROUND: To assess the measurement properties of the Benign Prostatic Hyperplasia Impact Index (BII) for use in men with Lower Urinary Tract Symptoms (LUTS) secondary to Benign Prostatic Hyperplasia (BPH) treated with tadalafil. METHODS: Data from a dose-titration (Study 1) and a dose-finding pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Angalakuditi, Mallik, Seifert, Rita F, Hayes, Risa P, O'Leary, Michael P, Viktrup, Lars
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998470/
https://www.ncbi.nlm.nih.gov/pubmed/21073697
http://dx.doi.org/10.1186/1477-7525-8-131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998470/
https://www.ncbi.nlm.nih.gov/pubmed/21073697
http://dx.doi.org/10.1186/1477-7525-8-131

Ejemplares similares